Academia.eduAcademia.edu

Outline

Cognitive impairment as a risk factor for psychosis

2005, Dialogues in Clinical Neuroscience

https://doi.org/10.31887/DCNS.2005.7.1/AREICHENBERG

Abstract

Since the time of Kraepelin and Bleuler, it has been recognized that schizophrenia is associated with a profound and persistent cognitive impairment. This paper reviews the major clinical and epidemiological studies of cognitive functioning in schizophrenia and other psychotic disorders, and presents several possible models to explain the association between cognitive impairment and psychosis. Cognitive impairment is present in the majority of patients with schizophrenia, and, in some, it is already evident in the premorbid stages of the disorder. This cognitive impairment is not secondary to psychotic symptoms, negative symptoms, or socioeconomic status. Cognitive impairment can also be observed in nonpsychotic family members of psychotic patients. On the basis of this evidence, it has been proposed that abnormal cognitive functioning can be considered as a possible causal risk factor for psychosis. Recent studies assessing the relationship between genetic background, cognition, br...

References (48)

  1. Kraepelin E. Dementia Praecox. Barclay RM, transl. Melbourne, Fla: Robert E. Krieger; 1913.
  2. Bleuler E. Dementia Praecox, or the Group of Schizophrenias (1911). New York, NY: International Universities Press; 1950.
  3. Green MF, Nuechterlein KH, Gold JM, et al. Approaching a consensus cog- nitive battery for clinical trials in schizophrenia: the NIMH-MATRICS con- ference to select cognitive domains and test criteria. Biol Psychiatry. 2004;56:301-307.
  4. Kremen WS, Seidman LJ, Faraone SV, Toomey R, Tsuang MT. The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol. 2000;109:743-752.
  5. Palmer BW, Heaton RK, Paulsen JS, et al. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology. 1997;11:437-446.
  6. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426-445.
  7. Saykin AJ, Gur RC, Gur RE, et al. Neuropsychological function in schizo- phrenia. Selective impairment in memory and learning. Arch Gen Psychiatry. 1991;48:618-624.
  8. Saykin AJ, Shtasel DL, Gur RE, et al. Neuropsychological deficits in neu- roleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 1994;51:124-131.
  9. Mohamed S, Paulsen JS, O'Leary D, Arndt S, Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry. 1999;56:749-754.
  10. Bilder RM, Goldman RS, Robinson D, et al. Neuropsychology of first- episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry. 2000;157:549-559.
  11. Censits DM, Ragland JD, Gur RC, Gur RE. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res. 1997;24:289-298.
  12. Nopoulos P, Flashman L, Flaum M, Arndt S, Andreasen N. Stability of cog- nitive functioning early in the course of schizophrenia. Schizophr Res. 1994;14:29-37.
  13. Gold S, Arndt S, Nopoulos P, O'Leary DS, Andreasen NC. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry. 1999;156:1342-1348.
  14. DeLisi LE, Tew W, Xie S, et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: prelimi- nary findings. Biol Psychiatry. 1995;38:349-360.
  15. Hoff AL, Sakuma M, Wieneke M, Horon R, Kushner M, DeLisi LE. Longitudinal neuropsychological follow-up study of patients with first- episode schizophrenia. Am J Psychiatry. 1999;156:1336-1341.
  16. Goldberg TE, Ragland JD, Torrey EF, Gold JM, Bigelow LB, Weinberger DR. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry. 1990;47:1066-1072.
  17. Goldberg TE, Torrey EF, Gold JM, Ragland JD, Bigelow LB, Weinberger DR. Learning and memory in monozygotic twins discordant for schizo- phrenia. Psychol Med. 1993;23:71-85.
  18. Cannon TD, Huttunen MO, Lonnqvist J, et al. The inheritance of neu- ropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet. 2000;67:369-382.
  19. Cannon TD, Zorrilla LE, Shtasel D, et al. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch Gen Psychiatry. 1994;51:651-661.
  20. Keefe RS, Silverman JM, Roitman SE, et al. Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Res. 1994;53:1-12.
  21. Egan MF, Goldberg TE, Gscheidle T, Weirich M, Bigelow LB, Weinberger DR. Relative risk of attention deficits in siblings of patients with schizo- phrenia. Am J Psychiatry. 2000;157:1309-1316.
  22. Egan MF, Goldberg TE, Gscheidle T, et al. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry. 2001;50:98-107.
  23. Kremen WS, Seidman LJ, Pepple JR, Lyons MJ, Tsuang MT, Faraone SV. Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull. 1994;20:103-119.
  24. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizo- phrenic patients: a 4-year follow-up study. J Abnorm Psychol. 1999;108:176-181.
  25. Gourovitch ML, Torrey EF, Gold JM, Randolph C, Weinberger DR, Goldberg TE. Neuropsychological performance of monozygotic twins dis- cordant for bipolar disorder. Biol Psychiatry. 1999;45:639-646.
  26. Murphy FC, Sahakian BJ. Neuropsychology of bipolar disorder. Br J Psychiatry. 2001;178(suppl 41):S120-S127.
  27. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord. 2002;72:209-226.
  28. Aylward E, Walker E, Bettes B. Intelligence in schizophrenia: meta-analy- sis of the research. Schizophr Bull. 1984;10:430-459.
  29. Jones P, Rodgers B, Murray R, Marmot M. Child development risk fac- tors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398-1402.
  30. Cannon M, Caspi A, Moffitt TE, et al. Evidence for early-childhood, pan- developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002;59:449-456.
  31. Cannon TD, Bearden CE, Hollister JM, Rosso IM, Sanchez LE, Hadley T. Childhood cognitive functioning in schizophrenia patients and their unaf- fected siblings: a prospective cohort study. Schizophr Bull. 2000;26:379-393.
  32. David AS, Malmberg A, Brandt L, Allebeck P, Lewis G. IQ and risk for schizophrenia: a population-based cohort study. Psychol Med. 1997;27:1311- 1323.
  33. Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry. 1999;156:1328-1335.
  34. Reichenberg A, Weiser M, Rabinowitz J, et al. A population-based cohort study of premorbid intellectual, language, and behavioral func- tioning in patients with schizophrenia, schizoaffective disorder, and nonpsy- chotic bipolar disorder. Am J Psychiatry. 2002;159:2027-2035.
  35. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660-669.
  36. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed). 1987;295:681-682.
  37. Cummings JL, Trimble MR. Neuropsychiatry and Behavioral Neurology Washington, DC: American Psychiatric Press; 1995.
  38. Cannon M, Jones PB, Murray RM. Obstetric complications and schizo- phrenia: historical and meta-analytic review. Am J Psychiatry. 2002;159:1080- 1092.
  39. Matte TD, Bresnahan M, Begg MD, Susser E. Influence of variation in birth weight within normal range and within sibships on IQ at age 7 years: cohort study. BMJ. 2001;323:310-314.
  40. Reid AH. Schizophrenia in mental retardation: clinical features. Res Dev Disabil. 1989;10:241-249.
  41. Erlenmeyer-Kimling L, Cornblatt B. The New York High-Risk Project: a follow-up report. Schizophr Bull. 1987;13:451-461.
  42. Erlenmeyer-Kimling L, Golden RR, Cornblatt BA. A taxometric analysis of cognitive and neuromotor variables in children at risk for schizophrenia. J Abnorm Psychol. 1989;98:203-208.
  43. Jones PB, Tarrant CJ. Developmental precursors and biological mark- ers for schizophrenia and affective disorders: specificity and public health implications. Eur Arch Psychiatry Clin Neurosci. 2000;250:286-291.
  44. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991;148:1474-1486.
  45. Glatt SJ, Faraone SV, Tsuang MT. Association between a functional cat- echol O-methyltransferase gene polymorphism and schizophrenia: meta- analysis of case-control and family-based studies. Am J Psychiatry. 2003;160:469-476.
  46. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophre- nia. Proc Natl Acad Sci U S A. 2001;98:6917-6922.
  47. Rosa A, Peralta V, Cuesta MJ, et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry. 2004;161:1110- 1112.
  48. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg TE, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002;159:652-654.